October Social Media Round-Up—Change the Odds, Forbes 2024 World’s Best Employers, and More

October was another eventful month here at Pfizer, and the evidence is all over our social media feeds.

CEO Albert Bourla closed out October by celebrating Pfizer’s strong Q3 earnings report, but that wasn’t all the good news we shared. Bourla also shined a spotlight on our one billionth dose of pneumococcal vaccine, while his colleagues recognized the company’s inclusion in the Forbes’ 2024 list of World’s Best Employers, reflected on our partnerships with Patrick Dempsey and the American Cancer Society to “Change the Odds” in cancer care, and much more.

Meanwhile, our corporate social channels went behind the scenes our latest vaccine R&D efforts, showcased the speed of Pfizer colleagues as they participated in the Tunnel to Towers 5K, and and released a new episode of “What’s in My Lab.”

Catch up below and follow our channels for more!

Executive Leadership

• CEO Albert Bourla proudly shares Pfizer’s strong Q3 earnings report
• Chief Oncology Officer Chris Boshoff shares our partnership with Patrick Dempsey in support of our “Change the Odds” initiative with the American Cancer Society to raise awareness of cancer disparities in underserved communities
• CEO Albert Bourla recognizes Pfizer’s annual Latino Community Summit and colleagues in honor of Hispanic Heritage Month
• Chief People Experience Officer Payal Sahni Becher highlights Forbes’ recognition of Pfizer as one of the World’s Best Employers of 2024
• CEO Albert Bourla shares his excitement for Pfizer’s Patients In Focus Week, an event series where we hear directly from the patients who drive our work
• Chief Corporate Affairs Officer Sally Susman looks ahead to the next 175 years with Pfizer, aiming to outdo yesterday
• CEO Albert Bourla meets with Pfizer colleagues at our R&D sites in Groton, Kendall Square, and Pearl River
• Chief People Experience Officer Payal Sahni Becher reflects on the importance of mental health and wellbeing in honor of World Mental Health Day
• CEO Albert Bourla shines a spotlight on Pfizer’s one billionth dose of pneumococcal vaccine supplied through Pfizer partner, Gavi, the Vaccine Alliance

Pfizer on LinkedIn

• Pfizer’s latest “Day in the Life” podcast episode dives into the experiences of a patient living with multiple myeloma
• Pfizer colleagues travelled to Rwanda to support Health Builders, a non-profit working to enable equitable access to healthcare for rural communities through the Global Health Fellows program
• Pfizer shares how we’re working to Change the Odds of cancer in the Hispanic community in collaboration with the American Cancer Society
• Pfizer kicks off the second Health Equity in Action Summit to explore community-based solutions with health equity leaders across the healthcare ecosystem
• Pfizer patient partner, Alayna, shares their story and experiences as a two-time Hodgkin lymphoma survivor
• Pfizer announces the election of Tim Buckley to Pfizer’s Board of Directors
• Pfizer colleagues and experts share how we’re driving breakthroughs for breast cancer patients

Pfizer on Instagram

• Pfizer partner, Patrick Dempsey, shares his personal story with cancer care and the importance of cancer screening and early detection in the latest “Front Porch Conversations” in collaboration with the American Cancer Society
• Pfizer looks ahead to the next 175 years, setting our sights on preventing, treating, and curing more conditions to outdo yesterday
• Pfizer partner, Ernie Hudson, shows the importance of RSV (respiratory syncytial virus) vaccination for certain adults 60+
• Pfizer shares our commitment to raising awareness for menopause on World Menopause Day

Pfizer on X

• The Pfizer Butterfly Community supports colleagues with chronic health conditions in their time of need
• Pfizer shares stories of resilience and healing in “Below Surface,” a documentary about the importance of community
• Pfizer takes you behind the scenes on how vaccines work and the latest efforts in our vaccine R&D
• Pfizer announces positive results in our Phase 3 study in men with metastatic castration-resistant prostate cancer (mCRPC)
• Pfizer Chief Oncology Medical Officer, Karin Tollefson, joins a panel at HLTH 2024 to discuss early-onset cancer cases

Pfizer on TikTok

• Pfizer colleagues take to the streets for the Tunnel to Towers 5K, honoring the first responders and civilians lost on 9/11
• Pfizer’s latest episode of “What’s In My Lab” takes you on a tour of Pfizer’s Compound Management Lab